The efficacy of radical antegrade modular pancreatosplenectomy: a systematic review and meta-analysis protocol

DISCLAIMER – FOR INFORMATIONAL PURPOSES ONLY; USE AT YOUR OWN RISK

The protocol content here is for informational purposes only and does not constitute legal, medical, clinical, or safety advice, or otherwise; content added to protocols.io is not peer reviewed and may not have undergone a formal approval of any kind. Information presented in this protocol should not substitute for independent professional judgment, advice, diagnosis, or treatment. Any action you take or refrain from taking using or relying upon the information presented here is strictly at your own risk. You agree that neither the Company nor any of the authors, contributors, administrators, or anyone else associated with protocols.io, can be held responsible for your use of the information contained in or linked to this protocol or any of our Sites/Apps and Services.

Background: Previous systematic reviews showed that radical antegrade modular pancreatosplenectomy (RAMPS) had good outcomes including the prognosis. However, recent large studies have shown opposite results, which is open to augment on RAMPS. The present study will aim to update the evidence on clinical outcomes of patients with left-sided pancreatic cancer underwent RAMPS compared to standard approach.

Methods: Electronic databases and registries will be searched to perform random-effect meta-analysis. Methodological quality will be assessed using the Grading of Recommendations, Assessment, Development, and Evaluation approach. The protocol will be registered (https://www.protocols.io/).

RAMPS SR&MA protocol.pdf